Cellectis SA
(NAS:CLLS)
$
1.56
0 (0%)
Market Cap: 154.13 Mil
Enterprise Value: -15.24 Mil
PE Ratio: 0
PB Ratio: 1.27
GF Score: 70/100 Cellectis SA at JMP Securities Life Sciences Conference Transcript
Jun 16, 2022 / 02:00PM GMT
Release Date Price:
$2.39
(-4.40%)
Silvan Türkcan
JMP Securities LLC - Analyst
Welcome back to the JMP Life Sciences Conference, the second day. My name is Silvan Türkcan. I'm a senior analyst covering precision medicines here. It's my pleasure to host Cellectis at today's conference. André Choulika, CEO and Founder; and Arthur Stril, Chief Business Officer. Thank you. Thanks for joining us today.
AndrÃ;Choulika
Cellectis SA - CEO & Board Director
© -
Thanks for inviting us.
Arthur Stril
Cellectis SA - Chief Business Officer
Thanks for inviting us.
Questions & Answers
Silvan Türkcan;AndrÃ;Choulika
JMP Securities LLC - Analyst;Cellectis SA - CEO & Board Director<
So, obviously, maybe we could start with your view about the allogeneic CAR T space coming out of all the data sets that we've seen at ACR, EHA, ASCO. The recent days, there have been a lot of updates. So can you just tell us how -- where are we now with ALLO?
©
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot